Login · Contact

Akorn Pharmaceuticals

Akorn Investor Relations
2018 Press Releases
Keyword Search
2018 | 2017
02/26/18Akorn Issues Statement on Investigation
LAKE FOREST, Ill., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today issued the following statement: “Akorn and Fresenius Kabi AG, with the assistance of outside consultants, are investigating alleged breaches of FDA data integrity requirements relating to product development at the Company.  To date, the Company’s investigation has not found any facts that would result in a material impact on Akorn’s operations and the Co... 
Printer Friendly Version